Explore / Clinical trial
Clinical trial

Different Doses of Dexmedetomidine Combined With Esketamine in Women Undergoing Cesarean Delivery

Peking University First HospitalCompletedPhase 4Started Oct 8, 2024120 enrolledChinaNCT06613243

Abstract

Esketamine is a commonly used analgesic during cesarean delivery, but may produce transient neuropsychiatric symptoms. Dexmedetomidine has both sedative and analgesic effects. When used in combination with esketamine, dexmedetomidine can reduce esketamine related neuropsychiatric effects after general anesthesia. The investigator speculate that combining low-dose dexmedetomidine with esketamine may also reduce neuropsychiatric adverse effects of esketamine in women undergoing cesarean section. This pilot trial is designed to determine the minimum dose of dexmedetomidine that can effectively prevent neuropsychiatric side effects of antidepressive dose esketamine (0.2mg/kg) in women undergoing cesarean delivery.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepression

Keywords

cesarean deliveryesketamineneuropsychiatric symptomsdexmedetomidineCesarean DeliveryEsketamineNeuropsychiatric SymptomsDexmedetomidine

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.